Selected research
Market Structure
Global Metabolomics Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Metabolomics Instrument market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Metabolomics Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metabolomics Instrument include Agilent, Metabolon, Bruker, Thermo Fisher, Biotree, Shimadzu Corporation, Biocrates Life Sciences AG, Waters Corporation and Metware, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Metabolomics Instrument output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Metabolomics Instrument by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Metabolomics Instrument market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Metabolomics Instrument and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Metabolomics Instrument sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metabolomics Instrument market size, projected growth trends, production technologies, key applications, and end-use industries.
Metabolomics Instrument Segment by Company
Agilent
Metabolon
Bruker
Thermo Fisher
Biotree
Shimadzu Corporation
Biocrates Life Sciences AG
Waters Corporation
Metware
LECO Corporation
Creative Proteomics
Human Metabolome Technologies
Diagnostic Solutions Laboratory
Applied Protein Technology
Metabolomics Instrument Segment by Type
Mass Spectrometry
Nuclear Magnetic Resonance
Gas Chromatography
Liquid Chromatography
Others
Metabolomics Instrument Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Others
Metabolomics Instrument Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabolomics Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metabolomics Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabolomics Instrument.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Metabolomics Instrument market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metabolomics Instrument industry.
Chapter 3: Detailed analysis of Metabolomics Instrument market competition landscape. Including Metabolomics Instrument manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Metabolomics Instrument by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Metabolomics Instrument in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Mass Spectrometry
- Nuclear Magnetic Resonance
- Gas Chromatography
- Liquid Chromatography
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Companies covered
- Agilent
- Metabolon
- Bruker
- Thermo Fisher
- Biotree
- Shimadzu Corporation
- Biocrates Life Sciences AG
- Waters Corporation
- Metware
- LECO Corporation
- Creative Proteomics
- Human Metabolome Technologies
- Diagnostic Solutions Laboratory
- Applied Protein Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metabolomics Instrument Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metabolomics Instrument Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Metabolomics Instrument Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Metabolomics Instrument Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Metabolomics Instrument Market Dynamics
- 2.1 Metabolomics Instrument Industry Trends
- 2.2 Metabolomics Instrument Industry Drivers
- 2.3 Metabolomics Instrument Industry Opportunities and Challenges
- 2.4 Metabolomics Instrument Industry Restraints
3 Metabolomics Instrument Market by Manufacturers
- 3.1 Global Metabolomics Instrument Production Value by Manufacturers (2021-2026)
- 3.2 Global Metabolomics Instrument Production by Manufacturers (2021-2026)
- 3.3 Global Metabolomics Instrument Average Price by Manufacturers (2021-2026)
- 3.4 Global Metabolomics Instrument Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metabolomics Instrument Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Metabolomics Instrument Manufacturers, Product Type & Application
- 3.7 Global Metabolomics Instrument Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metabolomics Instrument Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metabolomics Instrument Players Market Share by Production Value in 2025
- 3.8.3 2025 Metabolomics Instrument Tier 1, Tier 2, and Tier 3
4 Metabolomics Instrument Market by Type
- 4.1 Metabolomics Instrument Type Introduction
- 4.1.1 Mass Spectrometry
- 4.1.2 Nuclear Magnetic Resonance
- 4.1.3 Gas Chromatography
- 4.1.4 Liquid Chromatography
- 4.1.5 Others
- 4.2 Global Metabolomics Instrument Production by Type
- 4.2.1 Global Metabolomics Instrument Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Metabolomics Instrument Production by Type (2021-2032)
- 4.2.3 Global Metabolomics Instrument Production Market Share by Type (2021-2032)
- 4.3 Global Metabolomics Instrument Production Value by Type
- 4.3.1 Global Metabolomics Instrument Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Metabolomics Instrument Production Value by Type (2021-2032)
- 4.3.3 Global Metabolomics Instrument Production Value Market Share by Type (2021-2032)
5 Metabolomics Instrument Market by Application
- 5.1 Metabolomics Instrument Application Introduction
- 5.1.1 Academic and Research Institutes
- 5.1.2 Pharmaceutical and Biotechnology Companies
- 5.1.3 Others
- 5.2 Global Metabolomics Instrument Production by Application
- 5.2.1 Global Metabolomics Instrument Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Metabolomics Instrument Production by Application (2021-2032)
- 5.2.3 Global Metabolomics Instrument Production Market Share by Application (2021-2032)
- 5.3 Global Metabolomics Instrument Production Value by Application
- 5.3.1 Global Metabolomics Instrument Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Metabolomics Instrument Production Value by Application (2021-2032)
- 5.3.3 Global Metabolomics Instrument Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Agilent
- 6.1.1 Agilent Company Information
- 6.1.2 Agilent Business Overview
- 6.1.3 Agilent Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.1.4 Agilent Metabolomics Instrument Product Portfolio
- 6.1.5 Agilent Recent Developments
- 6.2 Metabolon
- 6.2.1 Metabolon Company Information
- 6.2.2 Metabolon Business Overview
- 6.2.3 Metabolon Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.2.4 Metabolon Metabolomics Instrument Product Portfolio
- 6.2.5 Metabolon Recent Developments
- 6.3 Bruker
- 6.3.1 Bruker Company Information
- 6.3.2 Bruker Business Overview
- 6.3.3 Bruker Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.3.4 Bruker Metabolomics Instrument Product Portfolio
- 6.3.5 Bruker Recent Developments
- 6.4 Thermo Fisher
- 6.4.1 Thermo Fisher Company Information
- 6.4.2 Thermo Fisher Business Overview
- 6.4.3 Thermo Fisher Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Metabolomics Instrument Product Portfolio
- 6.4.5 Thermo Fisher Recent Developments
- 6.5 Biotree
- 6.5.1 Biotree Company Information
- 6.5.2 Biotree Business Overview
- 6.5.3 Biotree Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.5.4 Biotree Metabolomics Instrument Product Portfolio
- 6.5.5 Biotree Recent Developments
- 6.6 Shimadzu Corporation
- 6.6.1 Shimadzu Corporation Company Information
- 6.6.2 Shimadzu Corporation Business Overview
- 6.6.3 Shimadzu Corporation Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.6.4 Shimadzu Corporation Metabolomics Instrument Product Portfolio
- 6.6.5 Shimadzu Corporation Recent Developments
- 6.7 Biocrates Life Sciences AG
- 6.7.1 Biocrates Life Sciences AG Company Information
- 6.7.2 Biocrates Life Sciences AG Business Overview
- 6.7.3 Biocrates Life Sciences AG Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.7.4 Biocrates Life Sciences AG Metabolomics Instrument Product Portfolio
- 6.7.5 Biocrates Life Sciences AG Recent Developments
- 6.8 Waters Corporation
- 6.8.1 Waters Corporation Company Information
- 6.8.2 Waters Corporation Business Overview
- 6.8.3 Waters Corporation Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.8.4 Waters Corporation Metabolomics Instrument Product Portfolio
- 6.8.5 Waters Corporation Recent Developments
- 6.9 Metware
- 6.9.1 Metware Company Information
- 6.9.2 Metware Business Overview
- 6.9.3 Metware Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.9.4 Metware Metabolomics Instrument Product Portfolio
- 6.9.5 Metware Recent Developments
- 6.10 LECO Corporation
- 6.10.1 LECO Corporation Company Information
- 6.10.2 LECO Corporation Business Overview
- 6.10.3 LECO Corporation Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.10.4 LECO Corporation Metabolomics Instrument Product Portfolio
- 6.10.5 LECO Corporation Recent Developments
- 6.11 Creative Proteomics
- 6.11.1 Creative Proteomics Company Information
- 6.11.2 Creative Proteomics Business Overview
- 6.11.3 Creative Proteomics Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.11.4 Creative Proteomics Metabolomics Instrument Product Portfolio
- 6.11.5 Creative Proteomics Recent Developments
- 6.12 Human Metabolome Technologies
- 6.12.1 Human Metabolome Technologies Company Information
- 6.12.2 Human Metabolome Technologies Business Overview
- 6.12.3 Human Metabolome Technologies Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.12.4 Human Metabolome Technologies Metabolomics Instrument Product Portfolio
- 6.12.5 Human Metabolome Technologies Recent Developments
- 6.13 Diagnostic Solutions Laboratory
- 6.13.1 Diagnostic Solutions Laboratory Company Information
- 6.13.2 Diagnostic Solutions Laboratory Business Overview
- 6.13.3 Diagnostic Solutions Laboratory Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.13.4 Diagnostic Solutions Laboratory Metabolomics Instrument Product Portfolio
- 6.13.5 Diagnostic Solutions Laboratory Recent Developments
- 6.14 Applied Protein Technology
- 6.14.1 Applied Protein Technology Company Information
- 6.14.2 Applied Protein Technology Business Overview
- 6.14.3 Applied Protein Technology Metabolomics Instrument Production, Value and Gross Margin (2021-2026)
- 6.14.4 Applied Protein Technology Metabolomics Instrument Product Portfolio
- 6.14.5 Applied Protein Technology Recent Developments
7 Global Metabolomics Instrument Production by Region
- 7.1 Global Metabolomics Instrument Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Metabolomics Instrument Production by Region (2021-2032)
- 7.2.1 Global Metabolomics Instrument Production by Region (2021-2026)
- 7.2.2 Global Metabolomics Instrument Production Forecast by Region (2027-2032)
- 7.3 Global Metabolomics Instrument Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Metabolomics Instrument Production Value by Region (2021-2032)
- 7.4.1 Global Metabolomics Instrument Production Value by Region (2021-2026)
- 7.4.2 Global Metabolomics Instrument Production Value by Region (2027-2032)
- 7.5 Global Metabolomics Instrument Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Metabolomics Instrument Production Value (2021-2032)
- 7.6.2 Europe Metabolomics Instrument Production Value (2021-2032)
- 7.6.3 Asia-Pacific Metabolomics Instrument Production Value (2021-2032)
- 7.6.4 South America Metabolomics Instrument Production Value (2021-2032)
- 7.6.5 Middle East & Africa Metabolomics Instrument Production Value (2021-2032)
8 Global Metabolomics Instrument Consumption by Region
- 8.1 Global Metabolomics Instrument Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Metabolomics Instrument Consumption by Region (2021-2032)
- 8.2.1 Global Metabolomics Instrument Consumption by Region (2021-2026)
- 8.2.2 Global Metabolomics Instrument Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Metabolomics Instrument Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Metabolomics Instrument Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Metabolomics Instrument Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Metabolomics Instrument Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Metabolomics Instrument Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Metabolomics Instrument Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Metabolomics Instrument Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Metabolomics Instrument Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Metabolomics Instrument Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Metabolomics Instrument Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Metabolomics Instrument Value Chain Analysis
- 9.1.1 Metabolomics Instrument Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Metabolomics Instrument Production Mode & Process
- 9.2 Metabolomics Instrument Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metabolomics Instrument Distributors
- 9.2.3 Metabolomics Instrument Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst